Online Submissions

Already have a Username/Password for Southern African Journal of Gynaecological Oncology?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.


Author Guidelines

Thank you for choosing to submit your paper to us. These instructions will ensure we have everything required so your paper can move through peer review, production and publication smoothly. Please take the time to read and follow them as closely as possible, as doing so will ensure your paper matches the journal's requirements. For general guidance on the publication process at Taylor & Francis please visit our Author Services website.

Editorial Manager
This journal uses Editorial Manager to peer review manuscript submissions. Complete guidelines for preparing and submitting your manuscript to this journal are provided below.

Preparing your paper
All authors submitting to medicine, biomedicine, health sciences, allied and public health journals should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, prepared by the International Committee of Medical Journal Editors (ICMJE).

Disclosure statement
Please include a disclosure of interest statement, using the subheading "Disclosure of interest". If you have no interests to declare, please state this (suggested wording: The authors report no conflicts of interest). Read more on declaring conflicts of interest.

Clinical Trials Registry
In order to be published in a Taylor & Francis journal, all clinical trials must have been registered in a public repository at the beginning of the research process (prior to patient enrolment). Trial registration numbers should be included in the abstract, with full details in the methods section. The registry should be publicly accessible (at no charge), open to all prospective registrants, and managed by a not-for-profit organization. For a list of registries that meet these requirements, please visit the WHO International Clinical Trials Registry Platform (ICTRP)WHO International Clinical Trials Registry Platform (ICTRP). The registration of all clinical trials facilitates the sharing of information among clinicians, researchers, and patients, enhances public confidence in research, and is in accordance with the ICMJE guidelines.

Complying with ethics of experimentation
Please ensure that all research reported in submitted papers has been conducted in an ethical and responsible manner, and is in full compliance with all relevant codes of experimentation and legislation. All papers which report in vivo experiments or clinical trials on humans or animals must include a written statement in the Methods section. This should explain that all work was conducted with the formal approval of the local human subject or animal care committees (institutional and national), and that clinical trials have been registered as legislation requires. Authors who do not have formal ethics review committees should include a statement that their study follows the principles of the Declaration of Helsinki.

All authors are required to follow the ICMJE requirements on privacy and informed consent from patients and study participants. Please confirm that any patient, service user, or participant (or that person’s parent or legal guardian) in any research, experiment, or clinical trial described in your paper has given written consent to the inclusion of material pertaining to themselves, that they acknowledge that they cannot be identified via the paper; and that you have fully anonymised them. Where someone is deceased, please ensure you have written consent from the family or estate. Authors may use this Patient Consent Form, which should be completed, saved, and sent to the journal if requested.

Health and safety
Please confirm that all mandatory laboratory health and safety procedures have been complied with in the course of conducting any experimental work reported in your paper. Please ensure your paper contains all appropriate warnings on any hazards that may be involved in carrying out the experiments or procedures you have described, or that may be involved in instructions, materials, or formulae.

Please include all relevant safety precautions; and cite any accepted standard or code of practice. Authors working in animal science may find it useful to consult the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare and Guidelines for the Treatment of Animals in Behavioural Research and Teaching. When a product has not yet been approved by an appropriate regulatory body for the use described in your paper, please specify this, or that the product is still investigational.
The Journal aims to be the prime journal on women's cancer for local health care workers and gynaecologists, focusing on all aspects of cancer prevention, detection, diagnosis and treatment. The SAJGO is also a specialist journal catering for sub-specialist gynaecologic oncologists, for other specialists with a specific interest in breast and gynaecologic cancer, including medical oncologists, radiation oncologists, surgeons, radiologists, pathologists, geneticists, specialised nurses and research scientists.

The Journal includes all aspects of female cancer prevention, diagnosis and treatment and aims to serve a broad readership. As such it should be of interest to the clinical, scientific and academic community, policy makers, government and non-government stakeholders and industry.

Cancer control programmes include primary and secondary prevention, early detection and effective treatment. These aspects form part of public health, general and specialist services and together form the important priorities of the journal.

HIV and AIDS remain problematic in the region with a severe impact on gynaecologic oncology. Papers focusing on gynaecological malignancies in HIV infected women will be prioritised. Research in this field needs to be encouraged.

The Journal encourages articles from all investigators in the fields of gynaecological and breast cancer. In particular young researchers and researchers from historically disadvantaged backgrounds will be encouraged and supported to submit their research work for publication.

Contributions from all African countries are especially welcomed. Manuscripts describing research performed at Southern African institutions and in African or developing settings will enjoy priority.

Article sections and length
The following contributions are accepted (word counts exclude abstracts, tables and references):

  • Original articles describe original investigations at an acceptable degree of completion, constituting an advance in the field. The body of the article must not exceed 3500 words of text. The abstract must either be structured and comprising no more than 250 words, or unstructured with a 200 word limit. Articles are limited to a maximum of 7 insets (tables and figures combined) and 50 references.

  • Review articles that are of high quality and of relevance to the field will be published. Manuscripts of Reviews will be peer reviewed and should not exceed 2500 words and 25 references. Reviews will often be invited and unsolicited reviews are also considered.

  • Brief Reports and Case Reports present complete studies that are narrower in scope than those described in Original articles. These Reports include a highly focused abstract and are limited to a total of no more than 1500 words of text, a total of 4 inserts (tables or figures), and 15 references. Preferably include "Brief Report" or "Case Report" in the title.

  • Pathologist's, Radiologist's and Surgeon's Corners intend to describe a specific issue, finding or technique that is new, of special interest or modified. This section is limited to 1000 words and up to 5 references and will be peer reviewed.

  • Correspondence (Letters to the Editor) should be short and concise, commenting on a recently published article in the Journal or a controversial or topical issue of concern to the readership. Please prepare the letter in manuscript format, including a title page. The letter must not exceed 500 words, 3 authors, 1 insert (table or figure) and 5 references. A statement of potential sources of conflict of interest must accompany the letter.

  • Editorials and Commentaries are generally invited by the Editor and are overviews of articles of other research or of issues of special interest to the subspeciality. Unsolicited commentaries are also considered.

Please see the journal's section policies section policies for further details.

Document requirements
Please include the following documents with your submission:
  • Cover letter stating that the manuscript has not been submitted or accepted for publication elsewhere and that it is the original work contributed to and approved by all the author(s).

  • Conflict of interest and funding statements.

  • Manuscript which should contain a title page, abstract, text and references. It may also contain tables and figures, acknowledgements and a foot note page.

Manuscript requirements
Title page
On the title page, please supply a running head of not more than 40 characters and spaces, a title of not more than 160 characters and spaces, the names and affiliations of all the authors in the correct sequence and word counts of the abstract and text. Each author?s first name, subsequent initials and surname must be used. Also supply the contact details of corresponding author.

Authorship should be based only on a substantial contribution to conception, analysis and interpretation of data; writing the article or revising it critically and final written approval of the version to be published. The Journal uses the Uniform Requirements of Authorship for Manuscripts Submitted to Biomedical Journals as published online at and all three of these conditions must be met.

The abstract may be structured with the headings Background, Methods, Results, and Conclusions (250-word limit) or unstructured (200-word limit). Abstracts of Brief Reports should be no more than 100 words. The abstract must state the purpose of the research, the methods, results and conclusions. Include up to 10 key words, separate from the abstract.

Please refer to the manuscript categories for the prescribed length of the text. The Editor reserves the right to shorten and stylise any material accepted for publication. Authors are solely responsible for the factual accuracy of their work.

The manuscript must be in English, should be in MS Word and follow the Vancouver style. Abbreviations and acronyms should be defined on first use. Pages should be numbered consecutively preferably with sections for introduction, materials and methods, results, discussion, acknowledgements followed by references.

Ethical considerations
The Methods section must include a statement that informed consent was obtained from patients, parents or guardians when appropriate. It should also state that the human experimentation guidelines of the National Department of Health ( and/or those of the authors? institution(s) were followed in the conduct of clinical research or that animal experimentation guidelines were followed in animal studies. Non-South African studies should contain similar declarations relating to local guidelines where appropriate. The trial number of the approving body (bodies) should be stated when relevant.

Tables and Figures
Refer to the manuscript categories for prescribed number of tables and figures. Written permission from the author or copyright holder must be submitted for reprint of previously published figures or tables. Figures should be saved as high resolution (300 dpi) jpeg files. Tables should be constructed in MS Word. Graphs can be copied from MS Excel and pasted in the document. For large, intricate graphs, the coordinates and graphs must be provided as separate MS Excel files and uploaded as supplementary files.

Tables and figures can be in the text at the relevant place. Large tables (landscape A4) and photographic images are best saved as separate supplementary files. Please number them appropriately.
Figures and photographs should be of high quality with symbols, letters or numbers clear enough and large enough to remain legible after reduction. Remove all markings, such as patient identification, from radiographs before photographing. Each figure must have a separate self-explanatory legend.

Examples of information that can be submitted as a footnote to the manuscript include:
  • Statement that authors either have or have not a potential conflict of interest.

  • Statement naming sources of financial support.

  • Information of previous presentation of part or all of the data.

  • Current affiliations and addresses for authors whose affiliations have changed since completion of the study.

  • Acknowledgements of financial support received or substantial contributions to the research or preparation of the manuscript made by persons other than the authors.

References should be cited in numerical order in the text, in superscript format (Format> Font> Click superscript) AFTER the full stops. (Not in brackets or as footnotes.)

References must be typed double-spaced and numbered consecutively in the order in which they are cited, not alphabetically.

The style for references should follow the format set forth in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals ( prepared by the International Committee of Medical Journal Editors. Abbreviations for journal titles should follow Index Medicus format.

Authors are responsible for the accuracy of all references. Personal communications and unpublished data should only be referenced in the text.

List all authors when there are six or fewer; when there are seven or more, list the first six, then "et al." When citing URLs to web documents, place in the reference list, and use the following format: Authors of document (if available). Title of document (if available). URL. (Accessed [date]).


Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. This manuscript has currently only been submitted to SAJGO and has not been published previously.
  2. This work is original and all third party contributions (images, ideas and results) have been duly attributed to the originator(s).
  3. Permission to publish licensed material (tables, figures, graphs) has been obtained and the letter of approval and proof of payment for royalties have been submitted as supplementary files.
  4. The submitting/corresponding author is duly authorised to herewith assign copyright to the SAJGO.
  5. All co-authors have made significant contributions to the manuscript to qualify as co-authors.
  6. Ethics committee approval has been obtained for original studies and is clearly stated in the methodology.
  7. A conflict of interest statement has been included where appropriate.
  8. The submission adheres to the instructions to authors in terms of all technical aspects of the manuscript.

Copyright Notice

By submitting manuscripts to SAJGO, authors of original articles are assigning copyright to the South African Society of Gynaecologic Oncology (SASGO). Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAJGO for educational and research purposes without obtaining permission.


Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.